Histone acetyltransferases (HATs) serve as coactivators of transcription that are important for proper regulation of gene expression (32) . Although much is known regarding the biochemical composition of HAT complexes, little is known regarding the functions of these enzymes in vivo. For example, few authentic gene targets have been identified for Gcn5, the prototypical transcription-related HAT (5), or for the highly related PCAF protein (41) .
Gcn5 and PCAF are assembled into large, multisubunit complexes in Saccharomyces cerevisiae, flies, and mammalian cells (4, 13, 23, 29) . The components of yeast Gcn5-containing complexes (SAGA, ADA, SALSA, and SLIK) have been characterized extensively (13, 14, 34) . Each complex has unique components as well as some shared Spt, Ada, and TATA box-binding protein-associated factor (TAF) proteins. In Drosophila melanogaster, Gcn5 is part of at least two complexes that contain different Ada2 homologs (20) . Mammalian Gcn5 is also part of multiple, related but distinct complexes, including STAGA and TFTC (4, 23, 29) that are remarkably similar to yeast SAGA in that they contain homologs of Ada2, Ada3, Spt3, Tra1 (PAF400), and several TAFs. STAGA and TFTC contain additional factors such as SAP130, an RNA splicing factor, and DDB1, which is involved in nucleotide excision repair, indicating that these complexes regulate processes other than transcription initiation (3, 7, 24) . Indeed, TFTC exhibits increased binding to UV-damaged DNA in vitro, suggesting this complex may play a direct role in sensing or repair of DNA damage in vivo (3) . Damage sensing might involve the p53 tumor suppressor, since both Gcn5 (our unpublished studies) and PCAF (21) acetylate p53 in vitro. Acetylation of p53 by these HATs and by p300/CBP is increased in vivo in response to DNA damage (1, 16) . However, how p53 acetylation affects DNA repair or repair checkpoints is not yet clear.
Mammalian Gcn5 contains at least three important functional domains (22) . An amino-terminal domain that is not present in the yeast enzyme mediates interactions with p300 and CBP (39) . The conserved bromodomain binds to acetyllysine moieties and may help anchor the enzyme at chromatin targets (36) . Critical conserved residues in the catalytic center of Gcn5 are required for acetyl coenzyme A binding and acetyltransferase activity (reviewed in reference 22). Mutation of a single glutamate (E173) in yeast Gcn5 that acts as a general base for catalysis reduces the specific activity of recombinant Gcn5 more than 300-fold (6, 35) . Mutation of this glutamate or of other conserved residues in the catalytic center cripples the ability of yeast Gcn5 to function as a coactivator in vivo, even though the mutant Gcn5 proteins are still incorporated into multisubunit complexes (6, 35) . Overexpression of these mutant forms of yeast Gcn5 are dominant negative relative to the wild-type protein, probably because SAGA subunits are sequestered into inactive HAT complexes (6) .
Despite extensive biochemical and structural analyses of Gcn5 complexes (22, 32) , the functions of this HAT in mammalian cells are not well defined. We and others have shown that deletion of Gcn5 in mice leads to embryonic death, indicating this HAT is essential for normal development (38, 40) . Gcn5 null embryos complete gastrulation but do not form somites, a neural tube, or a notochord. The lack of somite formation stems from a paucity of paraxial mesoderm, which is specified normally in the Gcn5 null embryos but is subject to increased levels of apoptosis (38) . In contrast, PCAF null mice are viable with no obvious abnormalities (38, 40) . Embryos deficient for both Gcn5 and PCAF die much earlier than Gcn5 single mutants, however, indicating that PCAF does contribute to some early developmental processes (38) .
Our original Gcn5 null allele deleted all Gcn5 coding sequences, thereby completely abolishing Gcn5 functions (38) .
The early death of Gcn5 null embryos precluded determination of Gcn5 functions later in development. Here we report that deletion of the p53 tumor suppressor allows Gcn5 null embryos to survive longer. However, Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ double mutants still die by embryonic day 11.5 (E11.5) with abnormal morphology. Mouse embryos homozygous for point mutations in the predicted catalytic domain of the murine Gcn5 sequence develop much further than either Gcn5 Ϫ/Ϫ or Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ null mice, surviving until E16.5. Cranial neural tube closure is defective in these Gcn5 HAT mutant mice, leading to exencephaly. Collectively, our data demonstrate that Gcn5 has important functions during development that are independent of its HAT activity, but Gcn5 HAT activity is critical for cranial neural tube closure.
MATERIALS AND METHODS
Creation of Gcn5 HAT mutation gene replacement vector. Genomic sequences covering the entire Gcn5 coding region were isolated previously (39) . The targeting vector was constructed by placing a 6.9-kb XbaI/EcoRV genomic fragment containing exons 8 to 19 of Gcn5 into Bluescript KS(ϩ). The E568A mutation was introduced into exon 12, and D609A was introduced into exon 13 of Gcn5 by site-directed mutagenesis. Primer sequences used for mutagenesis will be provided upon request. A PGKneobpA neomycin resistance expression cassette was inserted into intron 12 accompanying an EcoRI site. A MC1-TK (thymidine kinase) cassette was added at the 3Ј end for negative selection. For genotyping, genomic DNA was digested with EcoRI/EcoRV and probed with a 0.5-kb EcoRI/HindIII fragment (5Ј probe) or a 0.6-kb XbaI/EcoRI fragment (3Ј probe).
Creation of Gcn5 hat/؉ mice. The Gcn5 targeting vector was linearized and electroporated into 129/SvEv-derived embryonic stem (ES) cells (AB1). Doubly resistant cells [resistant to G418 and 1-(2-deoxy-2-␤-D-arabinofuranosyl)-Siodouracid (FLAU)] were genotyped by Southern blot analyses using probes described above. Correctly targeted ES clones were microinjected into C57BL/6J blastocysts. Chimeras were mated with wild-type C57BL/6J mice, and heterozygotes were identified among agouti progeny by Southern blot analysis of tail genomic DNA using the probes described above. Heterozygous mice were intercrossed to generate mice homozygous for the Gcn5 point mutations.
Genotyping of embryos. PCR-based genotyping was performed using primers specific for the Gcn5 wild-type allele, WL4 5Ј-TCACTATCTCGGATGGCTT-3Ј and WL5Y 5Ј-ACAGCTACGGCACAACTC-3Ј (800 bp), or the deletion allele, WL4 and WL6Y 5Ј-CTCTTCGCTATTACGCCAG-3Ј (440 bp). Dimethyl sulfoxide (6%) was added to the PCR mixtures. PCR conditions were 1 cycle of 1 min at 94°C; 5 cycles of 30 s at 94°C, 40 s at 63°C, and 1 min at 68°C; 30 cycles of 30 s at 94°C, 40 s at 55°C, and 1 min at 72°C; and 1 cycle of 7 min at 72°C.
To identify embryos carrying the Gcn5 catalytic site mutations, PCR amplification of yolk sac DNA was performed with the following primers: for E568A mutation in exon 12, 5Ј-CTTTCAGGGTTCCGTTCCTG-3Ј and 5Ј-TCTCACA GTAGACCAGGCTG-3Ј (547 bp); for D609A mutation in exon 13, 5Ј-ACTCA AGTGCTGAGTCTGGC-3Ј, 5Ј-CCCCCAAAGGACCTTCCAAT-3Ј (425 bp). PCR conditions were 1 cycle of 5 min at 95°C, 35 cycles of 1 min at 95°C, 1 min at 65°C, and 1 min at 72°C; and 1 cycle of 5 min at 72°C. The PCR products were then digested with PvuI to detect the E568A mutation (yielding 333-bp and 214-bp products) or PstI to detect the D609A mutation (yielding 223-bp and 202-bp products) as shown below (see Fig. 3C ).
Genotyping for the p53 allele was performed as described previously (27) . HAT assays. Full-length murine Gcn5 cDNA sequences (wild type or with catalytic site mutations) were subcloned into pRSETB vector and expressed in Escherichia coli BL2l bacterial cells. His 6 -tagged proteins were induced by the addition of isopropyl-␤-D-thiogalactopyranoside (IPTG). HAT assays were performed as described previously (26) .
Staging of mouse embryos. Mouse embryos were staged according to the time of maternal plugging and the observed number of somites in the embryos (28) .
Sectioning of mouse embryos. Mouse embryos were fixed in 4% paraformaldehyde (PFA) overnight at 4°C, dehydrated in graded solutions of alcohol, cleared in xylene, and embedded in paraffin. Five-or 6-m sections were generated from paraffin-embedded embryos using a Leica RM 2145 processor.
Section immunohistochemistry. Section immunohistochemistry was performed on 5-or 6-m sections of paraffin-embedded E8.5 embryos using the following antibodies: CM5 (NovoCastra NCL-p53-CM5p), cleaved caspase 3 (Asp175) (Cell Signaling Technology; 1:200 dilution), or phospho-histone H3 (Ser10) (Cell Signaling Technology; 1:50 dilution), according to the manufacturer's instructions as described in the mouse-on-mouse (M.O.M.) kit from Vector Labs. High-temperature antigen unmasking was performed for all slides. Briefly, slides were placed in coplin jars containing 0.01 M sodium citrate (pH 6.0). The citrate solution and slides were brought to a boil in a microwave. The coplin jar was then removed from the microwave and allowed to cool to room temperature before slides were removed for further processing. The 3,3Ј-diaminobenzidine (DAB) substrate kit (Vector Labs) was used for visualization of the peroxidase substrate.
TUNEL assays. Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays were performed on 6-m paraffin sections using the FragEL DNA fragmentation detection kit (Oncogene). The manufacturer's TdT-FragEL detailed protocol was followed, except that the volume of enzyme was halved and the termination of labeling reaction step was abridged.
Whole-mount in situ hybridizations. Sense and antisense RNA probes were synthesized from linearized plasmids by in vitro transcription using digoxigeninlabeled dUTP (Epicenter Technologies). The cDNAs used to generate probes for Fgf8, Shh, En-1, and Twist were provided by R. Johnson (University of Texas M. D. Anderson Cancer Center [UTMDACC]) or R. Behringer (UTMDACC). Whole embryos were fixed overnight in phosphate-buffered saline (PBS) containing 4% PFA at 4°C and dehydrated in a graded methanol series prior to storage at Ϫ20°C. Whole-mount in situ hybridization was performed as described previously (38) . Briefly, embryos were rehydrated in a graded methanol series and treated with 10 g/ml proteinase K (QIAGEN). The embryos were refixed with 0.2% glutaraldehyde-4% PFA and washed in PBS containing 0.1% Tween 20 prior to hybridization overnight at 70°C. Embryos were washed three times in 5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-1% sodium dodecyl sulfate (pH 4.5) at 70°C, followed by three washes in 2ϫ SSC at 65°C. Staining was visualized using a nitroblue tetrazolium-BCIP (5-bromo-4-chloro-3-indolylphosphate) (Roche) or BM purple (Roche) substrate.
Preparation of mouse embryos for scanning electron microscopy. Freshly dissected embryos were treated with a fixative containing 3% glutaraldehyde plus 2% PFA in 0.1 M cacodylate buffer, pH 7.3, for at least 1 h at ambient temper- a Significantly different from the expected number (P Ͻ 0.001 by chi-square analysis).
b Empty deciduas were observed at these time points. c Significantly different from the expected number (P Ͻ 0.05 by chi-square analysis).
d Significantly different from the expected number (P Ͻ 0.1 by chi-square analysis).
ature. Embryos were then washed with 0.1 M cacodylate buffer (pH 7.3) three times for 5 min each time. The embryos were then fixed with 1% cacodylatebuffered osmium tetroxide for 1 h and washed with distilled water three times for 5 min each time. The embryos were sequentially treated with Millipore-filtered aqueous 1% thiocarbohydrazide for 10 min, aqueous 1% osmium tetroxide for 10 min, 1% aqueous tannic acid for 30 min, and 1% aqueous uranyl acetate overnight in the dark. The embryos were rinsed thoroughly with distilled water after every treatment to prevent any carryover of reagents. The samples were then dehydrated with a graded series of increasing concentrations of ethanol for 5 min each. The embryos were then transferred to graded series of increasing concentrations of hexamethyldisilazane (HMDS) for 5 min each and air dried overnight. Samples were mounted on double-stick carbon tabs (Ted Pella, Inc., Redding, CA), which had been previously mounted onto aluminum specimen mounts (Electron Microscopy Sciences, Ft. Washington, PA). The samples were then coated under vacuum using a Balzer MED 010 evaporator (Technotrade International, Manchester, NH) with platinum alloy for a thickness of 25 nm and then immediately flash carbon coated under vacuum. The samples were transferred to a desiccator until examination in a JSM-5900 scanning electron microscope (JEOL, USA, Inc., Peabody, MA) at an accelerating voltage of 5 kV.
Isolation of primary MEFs. Brains, limbs, and internal organs were removed from freshly dissected E13.5 embryos, and the remaining tissues were transferred to a six-well plate, rinsed in 4 ml of PBS, and then transferred to new wells containing 1 ml of 0.25% (wt/vol) trypsin. Embryos were minced with a sterile razor blade and homogenized by repeated pipetting. After 10 min of incubation at 37°C, the cells were pipetted again to further separate clumps, and then 2 ml of mouse embryo fibroblast (MEF) medium (Dulbecco modified Eagle medium with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 0.1 mM ␤-mercaptoethanol) was immediately added to the well, and the cell suspension was divided among three 10-cm gelatinized culture plates. The medium was changed the next day, and the cells were grown to confluence at 37°C (passage 0) prior to splitting the cells 1:3 into fresh medium. After passage 6, cells were split 1:2. For the growth curve analyses shown below (see Fig. 7B ), third passage MEFs were seeded at 1 ϫ 10 5 cells per well of a six-well plate on day 0. The cells in duplicate plates were trypsinized, washed in PBS, and then stained in 0.4% trypan blue at the indicated time points. Trypan blue-negative cells were counted using a hemacytometer.
PI staining of MEFs. MEFs (2 ϫ 10 6 cells) were resuspended in 2 ml of PBS and vortexed gently prior to the addition of 5 ml of 95% ethanol. Cells were allowed to fix in the ethanol solution at room temperature for 30 min and then stored at 4°C. Just prior to flow cytometry, cells were collected by centrifugation at 3,000 ϫ g for 5 min and stained with propidium iodide (PI) (50 g/ml in PBS) (Sigma). RNase (100 l of 1 mg/ml stock of DNase-Free RNase; Sigma) was then added, and cells were incubated for 30 min at 37°C. Flow cytometry was performed at the UTMDACC core facility.
Annexin V-FITC staining of MEFs. MEFs were trypsinized, washed twice with cold PBS, and counted using a hemacytometer. Cells (1 ϫ 10 6 ) were collected and then resuspended in binding buffer (annexin V-FITC apoptosis detection kit 1; BD Biosciences). Cells were vortexed gently, and 100 l of the solution (1 ϫ 10 5 cells) was transferred to a 5-ml tube, followed by addition of 5 l of annexin V-fluorescein isothiocyanate (FITC) and 5 l of PI. The cells were gently vortexed again and incubated for 15 min at room temperature in the dark. Binding buffer (400 l) was added to each tube, and the stained cells were subjected to flow cytometry.
Preparation of MEF lysates and immunoblots. Whole-cell lysates were prepared by lysing MEFs directly in Laemmli gel loading buffer with protease inhibitors, followed by sonication on ice three times for 3 seconds each time and centrifugation at 12,000 ϫ g for 30 min at 4°C in a microcentrifuge to remove cellular debris. Nuclear extracts were prepared by lysing MEFs in buffer A (10 mM Tris, 1.5 mM MgCl 2 , 10 mM HCl. 0.5 mM dithiothreitol, and 0.2 mM phenylmethylsulfonyl fluoride). The lysate was held on ice for 10 min and homogenized 10 times. The nuclear pellet was collected by centrifugation as described above and then resuspended in buffer C (20 mM Tris, 0.42% NaCl, 25% glycerol, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, and 0.2 mM phenylmethylsulfonyl fluoride). After 30 min of rotation at 4°C, the extract was cleared by centrifugation as described above, and the supernatant (the nuclear extract) was removed and placed in a fresh tube. Proteins in whole-cell lysates or nuclear extracts were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. Histone H3 was detected using antisera specific for H3 acetylated at lysine 9 (K9) and lysine 18 (K18) (1:1,000 dilution [12] ), acetylated at K14 (1:1,000; Upstate) or the C terminus of H3 (1:2,000 dilution; Abcam). Histone H4 was detected using an antisera specific for K12 acetylated isoforms (1:1,000; Upstate) or total H4
(1:2,000; Upstate). The anti-Gcn5 antiserum used in these experiments was from BioLegend (1:500 dilution), and the anti-␤-actin antiserum was from Sigma (1:4,000 dilution).
RESULTS
Gcn5 mutants survive longer in the absence of p53. Our previous studies revealed that Gcn5 Ϫ/Ϫ mouse embryos are malformed by E8.5 and exhibit increased apoptosis relative to wild-type or heterozygous littermates as early as E7.5 (38) .
Other studies in our lab demonstrated that the increased apoptosis is p53 dependent, as it is not observed in Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ double mutant embryos were significantly smaller than their littermates at all times examined (Fig.  1) . Unlike Gcn5 Ϫ/Ϫ single mutants (38) , Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos had a distinct anterior-posterior axis, head folds, and somites (Fig. 1C, F, and I) . However, the double mutants had fewer somites (1 to 5 somites) at E8.5 than their littermates did (7 to 13 somites). At later times, the double null embryos remained smaller than their littermates, were slow to turn, and appeared delayed in development ( Fig. 1F and I) . In contrast, Gcn5 ϩ/Ϫ p53 Ϫ/Ϫ embryos were indistinguishable from their Gcn5 ϩ/ϩ p53 Ϫ/Ϫ littermates (compare Fig. 1A , D, and G to Fig. 1B, E, and H) .
To further determine the extent of development achieved by the double mutants, we analyzed the expression of several marker genes at E8.5 to E9.0 (Fig. 2) . The timing and extent of Fgf8 (fibroblast growth factor 8; Fig. 2A ), Dll1 (delta1 like 1; Fig. 2B ), and Tcf15 (paraxis; data not shown) expression in the E8.5 Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos were unchanged relative to Gcn5 wild-type (Gcn5 ϩ/ϩ p53 Ϫ/Ϫ ) or heterozygous (Gcn5 ϩ/Ϫ p53 Ϫ/Ϫ ) littermates, consistent with the normal timing and spatial development of a primitive streak followed by formation of presomitic mesoderm and somites. Shh (sonic hedge hog) expression was observed along the anterior midline and floor plate of both Gcn5 ϩ/Ϫ p53 Ϫ/Ϫ and Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos (Fig. 2C) , indicating normal initiation of notochord formation in the double mutants. Expression of En-1 (engrailed 1) and Twist also occurred with similar timing and placement in the double null embryos as in control littermates ( Fig. 2D and  E) . Similarly, normal expression of Otx2 was observed from the anterior tip of the neural plate to the mesencephalon-metencephalon border of E9.0 Gcn5 (Fig. 2F) . Altogether, these data indicate that elimination of p53 allows Gcn5 Ϫ/Ϫ embryos to survive longer and to initiate somite and notochord formation. Our marker analyses indicate that anterior and midbrain development also initiates in the Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos along the same time frame as in Gcn5 ϩ/ϩ p53 Ϫ/Ϫ or Gcn5 ϩ/Ϫ p53 Ϫ/Ϫ embryos. Gcn5, then, is not needed for these processes but is required for the normal patterning and survival of mouse embryos.
Gcn5 HAT mutations cause embryonic lethality. To determine whether Gcn5 acetyltransferase activity is required for its functions during mouse development, we created mice bearing mutations in the Gcn5 catalytic center. We generated a gene replacement vector for Gcn5 in which the critical catalytic glutamate (E568; equivalent to E173 in yeast Gcn5) (22) as well as a conserved aspartate (D608) were converted to alanine (Fig. 3A) . ES cell clones bearing the mutant allele integrated into the Gcn5 locus were identified by Southern blotting and 
(C) PCR genotyping to confirm the presence of the point mutations in Gcn5
hat/hat embryos. PCR products flanking each mutation site were generated as described in Materials and Methods (top blot). The E568A mutation is linked to a PvuI restriction site, and the D609A mutation is linked to a PstI restriction site. Cleavage of the PCR products by these enzymes (bottom blots) confirms the presence of the mutations. The two PstI cleavage products are close in size (202 and 223 bp) and migrate as a single band.
VOL. 27, 2007 NEURAL TUBE DEFECTS IN Gcn5 MUTANTS 3409
PCR genotyping and were then used to generate mice heterozygous for the Gcn5 HAT mutation (Gcn5 hat/ϩ ) ( Fig. 3B  and C) .
Gcn5 hat/ϩ mice appeared normal and were fertile. However, no live homozygous Gcn5 hat/hat mice were identified among 237 progeny of Gcn5 hat/ϩ intercrosses ( Table 2 ), suggesting that loss of Gcn5 HAT activity causes embryonic lethality. Indeed, Gcn5 hat/hat homozygotes were observed at expected frequencies at E8.5 to E11.5 but were found at reduced frequency at most later times of gestation ( Table 2) .
The negative effects of the E568A and D608A mutations on Gcn5 catalytic activity were confirmed in vitro by HAT assays using mutant and wild-type recombinant Gcn5 with isolated histones as the substrate (Fig. 4A) . Expression of the mutant Gcn5 protein in primary fibroblasts isolated from embryos (MEFs) was not significantly affected by the HAT mutations (Fig. 4B) , so the lethality of the Gcn5 hat/hat is not likely due to alterations in Gcn5 expression levels. Global levels of H3 acetylation at K9/K18 were slightly reduced in both Gcn5 hat/ϩ and Gcn5 hat/hat MEFs, but no reduction was seen in the levels of H3 K14 acetylation (Fig. 4C) . Levels of H4 K12 acetylation were also slightly reduced, consistent with reports that Gcn5 complexes in Drosophila acetylate this site (9) . The overall persistence of H3 and H4 acetylation in the Gcn5 hat/hat MEFs likely reflects the activities of several other HATs in these cells.
At E8.5, the Gcn5 hat/hat embryos exhibited two distinct morphologies ( Fig. 5B and B'; Fig. 6A ). Some of these embryos (15 of 44 [34%]) were quite small and did not develop somites ( Table 2 and Fig. 5B') , a phenotype very similar to that of embryos homozygous for a complete deletion of Gcn5 (38 5B ) and were more similar to their wild-type littermates (Fig.  5A) , developing somites and head folds, structures not observed in the Gcn5 deletion mutants. PCR genotyping and restriction digestions confirmed that embryos with both phenotypes contained both the E568A and D609A mutations (data not shown). The molecular basis for the differences in phenotype among the Gcn5 hat/hat embryos at E8.5 is not known, but TUNEL analyses indicated that the smaller, less developed Gcn5 hat/hat embryos had elevated levels of apoptotic cells at E8.5 (Fig. 6A, right bottom panel) , similar to that we reported previously for Gcn5 null embryos (Fig. 6A , left bottom panel) (38) . No such increase in apoptosis (relative to Gcn5 hat/ϩ or wild-type littermates) was observed in the larger, more developed Gcn5 hat/hat embryos as assayed by TUNEL analyses (Fig. 6A, top panel) or immunostaining for activated caspase 3 (Fig. 6B) , indicating that the loss of Gcn5 HAT activity is not sufficient to induce this phenotype.
Similar levels of immunostaining for H3 serine 10 phosphorylation, which marks mitotic cells, were also observed in both wild-type and Gcn5 hat/hat embryos (Fig. 7A) , suggesting cell proliferation was not grossly affected by loss of Gcn5 catalytic activity. To more accurately gauge the effects of the Gcn5 mutation on cell proliferation, we analyzed growth of MEFs isolated from E13.5 embryos. Proliferation of third passage MEFs isolated from Gcn5 hat/hat embryos was initially similar to that of third passage wild-type or Gcn5 hat/ϩ MEFs (Fig. 7B ), but doubling of the Gcn5 hat/hat mutant cells was somewhat slower 4 to 6 days after plating (Fig. 7B, days 4 to 6 ). Flow cytometry did not reveal any gross abnormalities in the cell cycle of Gcn5 hat/hat MEFs. Similar distributions of G 1 , S, and G 2 cells were detected in MEFs of all three genotypes from passages 2 to 10 (Fig. 7C) . No change in apoptosis, as detected by annexin V immunostaining, was observed in the mutant MEFs at any time (Fig. 7D) , consistent with normal (i.e., not increased) levels of apoptosis in the more developed Gcn5 hat/hat embryos from which the MEFs were isolated ( Fig.  6A and B) . These results indicate that Gcn5 catalytic activity is not required for overall cell survival or cell cycle progression. The reason for the slower growth of Gcn5 hat/hat MEFs is unclear.
Neural tube defects (NTDs) and exencephaly in Gcn5
hat/hat embryos. Gcn5 hat/hat embryos exhibited defects in neural tube closure early in development and exencephaly at later times (Fig. 5C to G) . Neural tube closure normally begins at three sites at E8.5. The neural folds lift and fuse first at the hind- a Significantly different from the expected number (P Ͻ 0.01 by chi-square analysis).
b Empty deciduas were observed at these time points. c The number in parentheses is the number of smaller mutants at E8.5.
brain/cervical boundary (site 1), followed by fusions at the midbrain/forebrain boundary (site 2), and finally, fusion at the rostral end of the neural tube (site 3) (10). Fusion then continues from these sites, leading to complete neural tube closure by E9.5. The neural folds of E9.5 Gcn5 hat/hat embryos remained open, despite the extensive posterior development of these embryos (Fig. 5C) . Exencephaly was seen in Gcn5 hat/hat embryos from E11.5 onwards (Fig. 5D to G) and was quite dramatic in some embryos (e.g., the rightmost embryo in Fig. 5F ).
To further define the nature of the NTDs in Gcn5
hat/hat embryos, we performed scanning electron microscopy on E9.5 embryos. As expected, neural tube closure was completed in wild-type littermates at this time point (Fig. 8A, left panel hat/ϩ , and Gcn5 hat/hat MEFs are shown. Numbers underneath the blots represent averages of signals from multiple blots. Acetylated H3 (Ac H3) or H4 levels were normalized to total H3 or H4, and levels in wild-type cells were set at 1.0.
FIG. 5. Gcn5
hat/hat embryos exhibit defects in neural tube closure and exencephaly. Lateral views of embryos at the indicated time points. (A) Wild-type embryo; (B and B') Gcn5 hat/hat embryos. In all other panels, the embryo on the left is a wild-type or Gcn5 hat/ϩ embryo, and the embryo on the right (and in the middle in panel F) is a Gcn5 hat/hat embryo. Fig. 5C to G; also data not shown). Normal neural tube fusion was achieved along the spinal region of the Gcn5 hat/hat embryos. Comparison of hematoxylin-and-eosin-stained lateral sections of wild-type and Gcn5 hat/hat E11.5 embryos revealed that the lack of the cranial vault in the mutants was associated with severe morphological changes in several areas of the brain, including the metencephalon, mesencephalon, and telecephalon (Fig. 8B) . These analyses also confirmed that development of posterior structures was not grossly affected in the mutant embryos. These data further establish the severity of the NTDs in the Gcn5 hat/hat embryos and indicate these defects are limited to the cranial region.
Expression of mesodermal and neural markers in Gcn5
hat/hat embryos. The cranial NTDs in the Gcn5 hat/hat embryos may reflect a failure of the neural folds to elevate in the midbrain region, thereby preventing fusion (10) . Alternatively, cranial NTDs might arise from defective development of head mesenchyme. Others have shown that decreased or increased numbers of head mesenchyme cells around the cranial neural tube lead to neural tube defects (8, 44, 45) . In addition, sonic hedge hog (Shh) signaling is required for proper bending of the neural folds to form the neural tube (10, 11) . To determine whether any of these steps is affected by loss of Gcn5 HAT activity, we compared the expression of key marker genes for these processes in Gcn5 hat/hat embryos to that in their wild-type or heterozygous littermates.
Whole-mount in situ hybridizations indicate that expression of Tcf15 occurs at the right time and place in Gcn5 hat/hat embryos (Fig. 9A) . Together with our data above demonstrating normal expression of Fgf8 and Dll in Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos ( Fig. 2A and B) , these findings indicate that neither Gcn5 expression nor HAT activity is required for presomitic mesoderm formation. Levels and location of Twist expression also appeared normal in E9.0 Gcn5 hat/hat embryos (Fig. 9B ), indicating that head mesenchyme is formed properly in the absence of Gcn5 HAT activity. En-1 expression was evident in the midbrain region of Gcn5 hat/hat embryos around E9.0 (Fig.  9C) . Expression of Shh occurred along the midline of the mutant animals, as is observed in wild-type littermates (Fig.  9D) . Otx2 was also expressed normally in the anterior and midbrain regions of E9.5 Gcn5 hat/hat embryos (Fig. 9E) . These data, then, indicate that the NTDs observed in the Gcn5 hat/hat embryos are not due to a failure in development of head mesenchyme or Shh expression. These data also indicate that Gcn5 HAT activity is not required for anterior, midbrain, or hindbrain specification. The NTDs in the Gcn5 hat/hat embryos must reflect deficiency in another process required for neural fold elevation and neural tube fusion.
DISCUSSION
Our previous work revealed that paraxial mesoderm and chordamesoderm are specified but do not survive in Gcn5 Ϫ/Ϫ embryos due to increased apoptosis relative to wild-type or heterozygous littermates (38) . We show here that elimination of the p53 tumor suppressor allows Gcn5 Ϫ/Ϫ embryos to survive longer and to develop somites. These results confirm our earlier conclusion that Gcn5 is not required for the specification of presomitic mesoderm but is required for the survival of this tissue lineage (in the presence of p53). We show here that loss of Gcn5 HAT activity is not sufficient to induce early embryo lethality but causes cranial NTDs, which culminate in exencephaly in mid-to late gestation. These findings demonstrate that Gcn5 HAT activity is required for proper neural tube closure in the mouse.
The phenotype of our Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ embryos was somewhat reminiscent of that reported by Yamauchi et al. for mouse mutants lacking Gcn5 C-terminal sequences, which encode the HAT domain and bromodomain (40) . Mice homozygous for that Gcn5 allele were smaller than their wild-type or heterozygous littermates and appeared delayed in development, just as we see in the Gcn5 Ϫ/Ϫ p53 Ϫ/Ϫ double null mutants.
The fact that those mutant embryos and our original Gcn5 null embryos die much earlier than our Gcn5 hat/hat embryos indicates that Gcn5 has important developmental functions that are independent of its acetyltransferase activity. Otherwise, the catalytic site mutations would render a phenotype just as severe as that of Gcn5 deletion. Gcn5-containing complexes in mice likely contain multiple functional modules, as they do in yeast (2, 19, 37) . Nonenzymatic proteins likely contribute essential functions to the complexes as well. In flies, for example, two Ada2 variants are assembled into separate Gcn5-containing complexes that have distinct roles during development (20) . The complete absence of the Gcn5 protein in our Gcn5 Ϫ/Ϫ mice (38) and the presence of (at most) a truncated protein in mice expressing the Gcn5 allele of Yamauchi et al. (40) might affect the integrity of all Gcn5-containing complexes in these mutant embryos. In contrast, complex integrity is predicted to be intact in our Gcn5 hat/hat mice on the basis of the precedent of catalytically inactive Gcn5 proteins in yeast (6, 35) . We have not yet tested this prediction, as we do not have immortalized cell lines expressing this allele, and biochemical purification would be difficult, if not impossible, from the limited amounts of embryonic material or primary MEFs that we could obtain. The fact that the Gcn5 hat/hat embryos survive until E13.5 to E16.5, though, supports the idea that this allele preserves important Gcn5 complex functions. Interestingly, overexpression of catalytically inactive forms of Gcn5 in yeast caused dominant-negative effects, likely due to competition of the mutant and wild-type forms of the proteins for assembly into SAGA or other Gcn5-containing complexes. We have not observed any dominant-negative effects of the mutant allele in our Gcn5 hat/ϩ mice, which likely reflects that normal expression (i.e., not overexpression) of the mutant allele in these mutant mice.
Gcn5 is expressed ubiquitously in early mouse embryos, with Ϫ/Ϫ single mutant embryos do, indicating PCAF shares some redundant functions with Gcn5 during development (38) . Similarly, the phenotype of mice heterozygous for null alleles of both Gcn5 and p300 exhibit decreased viability relative to mice heterozygous for either single mutation, indicating that Gcn5 and p300 share some functions during embryogenesis (31) . Mouse embryos with only one functional p300 allele exhibit an increased frequency of NTDs, indicating this HAT is also important for neural tube closure (42) . Interestingly, mutations in the acetyltransferase (AT) domain of p300 are dominant, unlike our Gcn5 AT domain mutations. The presence of a single p300 AT mutant allele results in defective development of the lungs, cardiovascular system, and small intestine in mice (33) . None of these organs are affected by loss of Gcn5 AT activity. Although these HATs physically interact and share some functions during development, they clearly have a number of distinct functions as well.
Neural tube closure is a complex and multistep process that involves lifting, bending, and fusion of the neural folds (10) . Alterations in tissue proliferation or in cell survival affect this process, but our data indicate that Gcn5 hat/hat fibroblasts divide somewhat slowly in vitro and are not subject to increased apoptosis. It seems likely, then, that Gcn5 affects neural tube closure through effects on cell growth and/or gene transcription. Gcn5 functions as a transcriptional coactivator, and although we found that Gcn5 HAT activity is not required for expression of Twist, En-1, Shh, or Otx2, it may regulate expression of one or more of the ϳ100 other genes required for proper neural tube closure (10, 45) . This possibility will be addressed in future studies.
Interestingly, another subunit of Gcn5-containing complexes, Ataxin-7, is also implicated in neural functions (17, 18, 25) . The Sca7 gene that encodes Ataxin-7 is subject to polyglutamine (poly-Q) expansions in humans, giving rise to spinocerebellar ataxia (15) . Mouse models of poly-Q expansions of Sca7 exhibit many phenotypes similar to those found in the human disease, including ataxia and retinal defects (15, 43) . Current models suggest that the mutant proteins have adverse (17) , but other studies indicate that poly-Q expanded Ataxin-7 proteins inhibit Gcn5 functions (25, 30) . Our current findings support the importance of Gcn5 acetyltransferase activity in normal neural development. The mutant Gcn5 alleles that we have generated will allow us to determine directly whether decreased Gcn5 protein levels or catalytic activity modulates the Sca7 poly-Q mutant phenotype in mice. 
